Christopher Aye is a member of the firm’s executive and investment committees. He is responsible for negotiating and structuring transactions, financial due diligence and ongoing oversight across the firm’s portfolio of investments.
Mr. Aye has decades of experience in finance and accounting, including public audit, financial planning and analysis, mergers and acquisitions and private equity. Prior to joining Skyview, Mr. Aye served on various matrix teams at Amgen Inc., including the team that ran the successful $16 billion post-acquisition integration of Immunex Corp. Also at Amgen, Mr. Aye held the key role of Financial Planning & Analysis, where he effectively co-managed a $150 million annual operating expense budget. Prior to Amgen, Mr. Aye served as a Senior Analyst in the M&A Transactions Group at Homestore.com, where he focused on financial and operational due diligence on potential acquisition targets. From 1998-2001, Mr. Aye was a CPA with Arthur Anderson LLP as a Senior Associate in the High Technology Audit Group, where he successfully advised start-up and emerging middle market technology companies through strategic M&A and IPO transactions.
Mr. Aye received a B.A. degree from the University of California, Santa Barbara, in Business Economics with a concentration in Accounting and his M.B.A. from the Marshall School of Business at the University of Southern California.